Anzeige
Mehr »
Samstag, 16.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C4QB | ISIN: FI4000480454 | Ticker-Symbol: 0TN
Frankfurt
15.08.25 | 15:29
1,365 Euro
-0,36 % -0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIORETEC OY Chart 1 Jahr
5-Tage-Chart
BIORETEC OY 5-Tage-Chart
RealtimeGeldBriefZeit
1,3301,34010:41

Aktuelle News zur BIORETEC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoBioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue273TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST This company announcement is a summary of Bioretec Ltd's half-year report...
► Artikel lesen
11.07.René Eve appointed as Director of Operations of Bioretec Ltd.2
27.06.Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue378TAMPERE, Finland, June 27, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST As previously announced, Bioretec Ltd ("Bioretec" or the "Company") has...
► Artikel lesen
26.06.New shares of Bioretec Ltd registered with the trade register5
BIORETEC Aktie jetzt für 0€ handeln
24.06.Final results of Bioretec Ltd's successful rights issue607TAMPERE, Finland, June 24, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY...
► Artikel lesen
23.06.Inside information: Preliminary result of Bioretec Oy's rights issue241Bioretec Ltd Inside information 23 June 2025 at 12.30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA...
► Artikel lesen
04.06.Bioretec Ltd publishes an exemption document relating to its rights issue298Bioretec Ltd Company announcement 4 June 2025 at 4:00 p.m. EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES...
► Artikel lesen
02.06.XFRA CAPITAL ADJUSTMENT INFORMATION - 02.06.2025912Das Instrument KOZ NO0003043309 KONGSBERG GRUPPEN NK 1,25 EQUITY wird cum Kapitalmassnahme gehandelt am 02.06.2025 und ex Kapitalmassnahme am 03.06.2025 The instrument KOZ NO0003043309 KONGSBERG GRUPPEN...
► Artikel lesen
28.05.Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue325Bioretec Ltd Inside information 28 May 2025 at 2.00 p.m. EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES...
► Artikel lesen
20.05.New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register464Bioretec Ltd Company announcement 20 May 2025 at 2.00 p.m. EEST TAMPERE, Finland, May 20, 2025 /PRNewswire/ -- An aggregate number of 60,000 new shares of Bioretec Ltd have been subscribed...
► Artikel lesen
15.05.Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec270Bioretec Ltd Inside information 15 May 2025 at 10.15 a.m. EEST TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- Bioretec's Board of Directors has appointed MBA Sarah van Hellenberg Hubar-Fisher...
► Artikel lesen
15.05.Bioretec Oy: Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec152Bioretec Ltd Inside information 15 May 2025 at 10.15 a.m. EEST Bioretec's Board of Directors has appointed MBA Sarah van Hellenberg Hubar-Fisher as the company's interim CEO. Van Hellenberg Hubar-Fisher...
► Artikel lesen
15.05.Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products390Bioretec Ltd Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March...
► Artikel lesen
08.05.Inside information: Bioretec's CEO Alan Donze to resign276Bioretec Ltd Inside information 8 May 2025 at 6:45 p.m. EET TAMPERE, Finland, May 8, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd announces that the company's...
► Artikel lesen
08.05.Bioretec Oy: Inside information: Bioretec's CEO Alan Donze to resign234Bioretec Ltd Inside information 8 May 2025 at 6:45 p.m. EET The Board of Directors of Bioretec Ltd announces that the company's CEO, Alan Donze, will resign from his position and will remain...
► Artikel lesen
21.03.Bioretec Ltd's Board of Directors has decided on a new option program for the CEO334Bioretec Ltd Company announcement 21st of March 2025 at 3:00 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd has on 21st of March 2025...
► Artikel lesen
21.03.Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors294Bioretec Ltd Company announcement 21 March 2025 at 2:30 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 21 March 2025...
► Artikel lesen
14.03.Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)367Bioretec Ltd Company announcement 14 March 2025 at 7:30 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has on 14 March 2025 received a notification in accordance...
► Artikel lesen
14.03.Bioretec Ltd's Annual Report 2024 published283Bioretec Ltd Press Release 14 March 2025 at 7:00 p.m. EET TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has today published its 2024 Annual Report. The Annual Report...
► Artikel lesen
07.03.Mirva Ekman appointed to Bioretec's Management Team as Quality Director1
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1